Prompted by the recent CAMEO trial publication on icatibant, we dive into angioedema with a focus on airway management.


https://media.blubrry.com/coreem/content.blubrry.com/coreem/Episode_107_0_Final_Cut.m4a



Download


Leave a Comment





Tags: ACE Inhibitors, Allergy/Immunology, Angioedema, Icatibant





Show Notes
Take Home Points


Airway management is paramount, expect a challenging intubation and consider controlling the airway early
When controlling the airway, consider an awake approach and fiberoptics if available. Always be prepared for the can’t intubate, can’t oxygenate scenario with a double set up.
If the patient has urticaria and pruritus, the process is likely histamine mediated and will respond to typical anaphylaxis treatment
Finally, observe the patient for progression of swelling and don’t forget to stop the inciting medication

Read More
Core EM: Angioedema
EMCrit: Podcast 145 – Awake Intubation Lecture from SMACC
ERCast: Angioedema
REBEL EM: Icatibant Doesn’t I...